Also known as: Fred Hutch, Fred Hutch Cancer Center
Recent studies highlight progress in monoclonal antibodies against measles, Lyme disease, and Epstein-Barr virus. A Phase I Lyme antibody trial showed lasting protection, while preclinical antibodies blocked EBV and measles infection.
Researchers identify DPY30 as an epigenetic target to sensitize pancreatic tumors to immunotherapy. UC San Diego researchers redirect CMV immunity against pancreatic cancer in preclinical models. A Fred Hutch researcher receives ACS grant to study immunotherapy resistance in melanoma.
President Trump signed a spending package funding the National Institutes of Health at nearly $49 billion, the highest level ever, reversing his earlier push for a 40% budget cut to medical research.
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT07739706 |
A Novel Smartphone Application for Helping Teens Stop Vaping, QuitQuest Vaping R01 |
NOT_YET_RECRUITING | NA |
| NCT07227571 |
Genetically Engineered Cells (FH-FOLR1 ST CAR T Cells) for the Treatment of Advanced Refractory or Recurrent/Progressive Osteosarcoma, FIERCe Trial |
RECRUITING | PHASE1 |
| NCT06995924 |
Improving Uptake of Surveillance in Colorectal Cancer Survivors Through Navigation and Web Education |
RECRUITING | NA |
| NCT06609057 |
Cooking for Your Health in Southern New Mexico: an 8-week, Bilingual (English and Spanish) Nutritional Intervention in Adults Living in Doña Ana and Otero Counties |
COMPLETED | NA |
| NCT05930496 |
Evaluating the Effects of an Exercise Intervention on the Gut Microbiota in Stage II-III Colorectal Cancer Survivors |
TERMINATED | NA |
| NCT05148845 |
Sisonke 2 - A COVID-19 Vaccine Boost Open Label Study. |
COMPLETED | PHASE3 |
| NCT04829136 |
Sustained Oral Fiber Supplementation for Patients Undergoing Treatment for Hematological Malignancies |
RECRUITING | NA |
